Blackstone’s $11.5 billion TXNM investment faces New Mexico review
New Mexico’s Supreme Court will decide whether regulators must apply a longstanding six-factor public-benefit standard when reviewing utility mergers. The commission has scheduled a January hearing, while several parties seek to pause proceedings until the court resolves the issue. TXNM and Blackstone refiled their application with nearly $300 million in customer benefits; hearings begin Jan. 19.
Blackstone seeks at least $3 billion for real estate secondaries fund
Blackstone’s Strategic Partners is seeking to raise at least $3 billion for a real estate secondaries fund, following a $2.6 billion predecessor in 2023. The fund will buy stakes in other managers’ core real estate vehicles at discounts to net asset value, focusing mainly on data centers, rental housing and industrial properties. The fundraising comes as investors and managers seek liquidity amid a sluggish real estate market.
Blackstone agrees to fund up to $1.5 billion of Pfizer obesity-drug development
Blackstone Life Sciences and BXPE will fund up to $1.5 billion of Pfizer’s berobenatide development costs through 2028. Blackstone may receive milestone payments tied to U.S. approval of monthly injectable dosing and sales targets. Pfizer retains all program rights, operational control, and decision-making. Berobenatide is an investigational monthly GLP-1 drug for obesity and related conditions.
Blackstone real estate earnings decline as property values face pressure
Blackstone’s real estate division is contracting as higher rates pressure property values, fees, and returns. Property AUM fell to $309 billion, and segment distributable earnings declined 10% year over year through the first nine months of 2026. Senior departures and a troubled $1.3 billion apartment loan add to concerns. Data centers and logistics, constrained new construction, and positive BREIT returns offer support.
Blackstone stock draws attention after Pfizer funding agreement
Blackstone is back in focus after Pfizer outlined a deal under which Blackstone may provide up to US$1.5 billion to support an experimental obesity drug. The stock has rebounded 6.3% over the past month but remains down about 18% over 90 days. Investors are also weighing Blackstone’s real estate secondaries push, Dubai wealth office and AI-focused data center platform against real estate risks and leadership transitions.
Blackstone opens Dubai private-wealth office to target Gulf investors
Blackstone held its first private-wealth investor gathering in Dubai and opened its first dedicated private wealth office outside Zurich, targeting a Gulf market where Dubai’s financial hub has family offices with more than $1 trillion in assets. The firm manages $330 billion through its private wealth business, nearly a quarter of its $1.4 trillion in assets, as it seeks new fundraising amid slower institutional flows.
Blackstone-led funds invest $535 million in IIFL Finance capital raise
IIFL Finance approved a Rs64.14bn ($686m) capital raise led by Blackstone funds, which will invest Rs50bn ($535m) through convertible preference shares. Promoters will contribute Rs12.6bn ($135m) through warrants, while Anchorage Capital will invest Rs1.5bn ($16m) in equity. The funding is intended to strengthen IIFL’s capital and support lending growth, particularly in gold finance, alongside investment in technology and governance.
Blackstone faces private-credit concerns despite record assets
Blackstone fell 24% amid concerns over private-credit redemptions, despite second-quarter distributable earnings rising 26% to $1.98 billion and assets under management reaching a record $1.35 trillion. Liontrust GF Global Dividend Fund initiated and then added to its position, citing Blackstone’s role in financing AI infrastructure, about $228 billion in dry powder, dividend growth, and expanding data-center and credit platforms.
Blackstone appoints David Levine and Giovanni Cutaia to lead real estate
Blackstone appointed David Levine and Giovanni Cutaia to lead its real estate business after Nadeem Meghji announced his departure. The unit’s profit is tracking at half its 2022 peak, distributable earnings fell 10% year over year, and assets remain $30 billion below their peak. Blackstone must deploy at least 70% of its $30 billion tenth flagship fund before raising a successor.
Blackstone-managed funds and Aon launch Lloyd’s reinsurance syndicate
Aon and Blackstone-managed funds are launching Cortina syndicate 1956, a Lloyd’s reinsurance syndicate managed by QBE. Subject to final Lloyd’s approval, it is expected to begin underwriting on January 1, 2027, providing dedicated multi-year capacity. Participating Aon clients will receive a dividend reflecting Cortina’s share of their programs; the syndicate plans to write 3% of eligible property catastrophe treaties and 5% of other eligible treaties.
Blackstone fee-related earnings rise as assets under management grow
Blackstone reported a slight Q3 2026 revenue decline, while fee-related earnings grew 6.2% and assets under management rose 10.2%. It declared a quarterly dividend and repurchased shares. A new private markets fund for non-U.S. investors expands its private wealth platform and could add recurring fee-based assets. Analyst forecasts anticipate revenue of US$22.1 billion and earnings of US$11.3 billion by 2029.
Blackstone shares trail peers despite asset growth and fund inflows
Blackstone shares have fallen 17% over the past year and 22.3% year to date, lagging the S&P 500 and alternative-asset peers. Third-quarter 2026 revenue edged down and distributable earnings fell, while fee-related earnings rose 6.2%, AUM grew 10.2% to $1.37 trillion, and inflows reached $63.3 billion. Shares gained 8.4% after results.
Blackstone group agrees to invest $3.1 billion in LNG Canada interest
Blackstone Credit & Insurance and Canadian institutional investors agreed to invest $3.1 billion for a 49.9% non-controlling stake in a Mitsubishi subsidiary holding Mitsubishi’s interest in LNG Canada. CPP Investments, OMERS, IMCO and PSP Investments are part of the investor group. Mitsubishi will remain the controlling partner and retain its full LNG offtake.
Blackstone Life Sciences commits $455 million to Boston Scientific heart-pump development
Blackstone Life Sciences will provide $455 million to co-fund Boston Scientific’s development of the VITALYST temporary heart pump for patients with cardiogenic shock. The device is intended to improve blood flow and address safety and efficacy needs in a high-mortality emergency.
Blackstone shares fall 23% as investors weigh growth and real estate risks
Blackstone shares fell 23% from US$154 at the start of 2026 to US$119, despite Q3 revenue of about US$2.92 billion, net income of US$662 million and net margin improving from 21.3% to 22.7%. Bullish and bearish investor narratives set fair values of US$182 and US$145, respectively. The article frames the price decline as a test of those assumptions, not as a definitive change in the company’s outlook.